Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Some patients experience headaches, constipation, and an unpleasant taste in the mouth
When glucose normalizes, insulin secretion falls, which helps reduce the risk of hypoglycemia
The Reality Is That Coverage Is Still Limited While demand for GLP-1 medications continues to rise, insurance coverage has not kept up
Current Availability Status Retatrutide remains in Phase 3 clinical trials as of early 2026
For most patients new to GLP-1 therapy, tirzepatide is the right starting point
Your team was flagging a cost alert: GLP-1 drug spend had tripled in six months
US$ 26.42
US$ 21.21
US$ 23.46
US$ 20.14
US$ 26.11
US$ 23.01
US$ 28.82
US$ 25.82
US$ 20.79
US$ 29.35
US$ 29.93
US$ 23.19
US$ 29.96
US$ 24.35
